Search research articles
Contact Us
Filters
Showing results (141-150 of 436) with videos related to
Page
of 44
Sort By:
Clinical Pharmacology and Therapeutics
|
July 9, 2021
US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines
Hussain S Lalani, Jerry Avorn, Aaron S Kesselheim
JAMA
|
March 6, 2014
What is the public's right to access medical discoveries based on federally funded research?
Carolyn L Treasure, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine
|
November 2, 2012
Risk, responsibility, and generic drugs
Aaron S Kesselheim, Jerry Avorn, Jeremy A Greene
The New England Journal of Medicine
|
February 9, 2022
A New Way to Contain Unaffordable Medication Costs - Exercising the Government's Existing Rights
Alfred B Engelberg, Jerry Avorn, Aaron S Kesselheim
JAMA
|
March 2, 2021
Paying for Prescription Drugs in the New Administration
Aaron S Kesselheim, Thomas J Hwang, Jerry Avorn
JAMA
|
June 7, 2011
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer
Aaron S Kesselheim, Jessica A Myers, Jerry Avorn
The New England Journal of Medicine
|
September 18, 2014
Antidepressant use in pregnancy and the risk of cardiac defects
Krista F Huybrechts, Sonia Hernández-Díaz, Jerry Avorn
The Annals of Pharmacotherapy
|
April 12, 2007
Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review
William Shrank, Jerry Avorn, Cony Rolon, et al.
The New England Journal of Medicine
|
October 16, 2009
Balancing innovation, access, and profits--market exclusivity for biologics
Alfred B Engelberg, Aaron S Kesselheim, Jerry Avorn
Journal of Health Politics, Policy and Law
|
May 21, 2014
Life cycle of medical product rules issued by the US Food and Drug Administration
Thomas J Hwang, Jerry Avorn, Aaron S Kesselheim
Page
of 44
Search research articles
Search
Showing results (141-150 of 436) with videos related to
Sort By:
Page
of 44
Clinical Pharmacology and Therapeutics
|
July 9, 2021
US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines
Hussain S Lalani, Jerry Avorn, Aaron S Kesselheim
JAMA
|
March 6, 2014
What is the public's right to access medical discoveries based on federally funded research?
Carolyn L Treasure, Jerry Avorn, Aaron S Kesselheim
The New England Journal of Medicine
|
November 2, 2012
Risk, responsibility, and generic drugs
Aaron S Kesselheim, Jerry Avorn, Jeremy A Greene
The New England Journal of Medicine
|
February 9, 2022
A New Way to Contain Unaffordable Medication Costs - Exercising the Government's Existing Rights
Alfred B Engelberg, Jerry Avorn, Aaron S Kesselheim
JAMA
|
March 2, 2021
Paying for Prescription Drugs in the New Administration
Aaron S Kesselheim, Thomas J Hwang, Jerry Avorn
JAMA
|
June 7, 2011
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer
Aaron S Kesselheim, Jessica A Myers, Jerry Avorn
The New England Journal of Medicine
|
September 18, 2014
Antidepressant use in pregnancy and the risk of cardiac defects
Krista F Huybrechts, Sonia Hernández-Díaz, Jerry Avorn
The Annals of Pharmacotherapy
|
April 12, 2007
Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review
William Shrank, Jerry Avorn, Cony Rolon, et al.
The New England Journal of Medicine
|
October 16, 2009
Balancing innovation, access, and profits--market exclusivity for biologics
Alfred B Engelberg, Aaron S Kesselheim, Jerry Avorn
Journal of Health Politics, Policy and Law
|
May 21, 2014
Life cycle of medical product rules issued by the US Food and Drug Administration
Thomas J Hwang, Jerry Avorn, Aaron S Kesselheim
Page
of 44